Antiva Biosciences: Clinical Trials

6 trials sponsored by Antiva Biosciences, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated. 6 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 4, Terminated 2
Phase 22Completed 1, Terminated 1

Follow Antiva Biosciences: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts
ABI-2280 - Human Papillomavirus Infection
Phase 1 / Phase 2CompletedAntiva Biosciences1412024-03-272026-08-17
A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Intraepithelial Neoplasia
ABI-2280 Vaginal Tablet/Insert - Cervical Intraepithelial Neoplasia
Phase 1 / Phase 2TerminatedAntiva Biosciences442022-09-102026-02-19
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.
Topical ABI-1968 - HSIL of Cervix, HSIL, High Grade Squamous Intraepithelial Lesions
Phase 1CompletedAntiva Biosciences82018-12-212021-01-13
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection
Topical ABI-1968 cream - HSIL, High-Grade Squamous Intraepithelial Lesions, Human Papilloma Virus Infection
Phase 1TerminatedAntiva Biosciences62018-12-172019-07-24
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
ABI-1968 - HSIL, HSIL of Cervix
Phase 1CompletedAntiva Biosciences162018-01-012019-07-10
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection
ABI-1968 - HSIL, High-Grade Squamous Intraepithelial Lesions, Human Papilloma Virus Infection
Phase 1CompletedAntiva Biosciences572017-08-112019-02-07

Conditions studied

Squamous Intraepithelial Lesions (4)  ·  Papillomavirus Infections (3)  ·  Uterine Cervical Dysplasia (3)  ·  Anus Neoplasms (2)  ·  HIV Infections (2)  ·  Uterine Cervical Neoplasms (2)  ·  Sexually Transmitted Diseases (1)

Interventions

Mutagenesis, Insertional (1)

Countries

Australia (5)  ·  United States (3)  ·  South Africa (2)  ·  Kenya (1)  ·  Mexico (1)  ·  New Zealand (1)  ·  Peru (1)